Insider · CIK 0001962407
Melita Sun Jung
officer
Files at TERN (Terns Pharmaceuticals, Inc.). First filing Feb 3, 2025, latest Feb 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$11k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Terns Pharmaceuticals, Inc. | $11k 2,250 shares | - | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 30, 2024 | TERN Terns Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +2,250 | $5.11 | $11k | 2,250 | Feb 3, 2025 |
| Jan 30, 2025 | TERN Terns Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +325,000 | $0.00 | $0 | 325,000 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.